Catechin-enriched green tea extract as a safe and effective agent for antimicrobial and anti-inflammatory treatment

African Journal of Pharmacy and Pharmacology

Volumn 5, Issue 12, 2011, Pages 1452-1461

  Wang, Y F ^a   Shao, S H ^a   Xu, P ^a   Yang, X Q ^a   Qian, L S ^a  

^a ZHEJIANG UNIVERSITY   (China)

Author keywords

Anti inflammatory; Antimicrobial; Catechin enriched green tea extract (CEGTE); Safety evaluation

Indexed keywords

ACETYLSALICYLIC ACID; ANTIINFECTIVE AGENT; ANTIINFLAMMATORY AGENT; CATECHIN ENRICHED GREEN TEA EXTRACT; UNCLASSIFIED DRUG;

AMES TEST; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ANTIMICROBIAL ACTIVITY; ANTIVIRAL ACTIVITY; ARTICLE; BACTERIOSTASIS; BACTERIUM ISOLATE; CONTROLLED STUDY; COXSACKIE VIRUS B4; DOSE TIME EFFECT RELATION; DRUG DOSE COMPARISON; DRUG EFFECT; DRUG EFFICACY; DRUG POTENCY; DRUG SAFETY; DRUG SCREENING; FEMALE; IN VITRO STUDY; IN VIVO STUDY; INFLUENZA VIRUS A H3N2; LD 50; MALE; MICRONUCLEUS TEST; MOUSE; MUTAGENICITY; NONHUMAN; OTITIS; PAW EDEMA; RAT; SEMEN ABNORMALITY; WRITHING TEST;

EID: 80054854873     PISSN: None     EISSN: 19960816     Source Type: Journal    
DOI: 10.5897/AJPP11.164     Document Type: Article

References (31)

1. Akai Y, Nakajima N, Ito Y, Matsui T, Iwasaki A, Arakawa Y (2007). Green tea polyphenols reduce gastric epithelial cell proliferation and apoptosis stimulated by Helicobacter pylori infection. J. Clin. Biochem. Nutr., 40: 108-115.
2. Bacquer DD, Clays E, Delanghe J, Backer GD (2006). Epidemiological evidence for an association between habitual tea consumption and markers of chronic inflammation. Atherosclerosis, 189: 428-435.
3. Bandyopadhyay D, Chatterjee TK, Dasgupta A, Lourduraja J, Dastidar SG (2005). In vitro and in vivo antimicrobial action of tea: The commonest beverage of Asia. Biol. Pharm. Bull., 28: 2125-2127.
4. Bergogne-Berezin E (2000). Treatment and prevention of antibiotic associated diarrhea. Int. J. Antimicrob. Agents, 16: 521-526.
5. Çavas T, Ergene-Gözükara S (2005). Genotoxicity evaluation of metronidazole using the piscine micronucleus test by acridine orange fluorescent staining. Environ. Toxicol. Phar., 19: 107-111.
6. Crouvezier S, Powell B, Keir D, Yaqoob P (2001). The effects of phenolic components of tea on the production of pro- and anti-inflammatory cytokines by human leukocytes in vitro. Cytokine, 13: 280-286.
7. Debette S, Courbon D, Leone N, Gariépy J, Tzourio C, Dartigues J, Barberger-Gateau P, Ritchie K, Alpérovitch A, Amouyel P, Ducimetière P, Zureik M (2008). Tea consumption is inversely associated with carotid plaques in women. Arterioscler. Thromb. Vasc. Biol., 28: 353-359.
8. El-Sayed NS, Rizk SM (2009). The protective effect of quercetin, green tea or malt extracts against experimentally-induced lung fibrosis in rats. Afr. J. Pharm. Pharmacol., 3: 191-201.
9. Finlay BB, McFadden G (2006). Anti-immunology: Evasion of the host immune system by bacterial and viral pathogens. Cell, 124: 767-782.
10. Glass CK, Saijo K, Winner B, Marchetto MC, Gage FH (2010). Mechanisms underlying inflammation in neurodegeneration. Cell, 140: 918-934.
11. Grivennikov SI, Greten FR, Karin M (2010). Immunity, inflammation, and cancer. Cell, 140: 883-899.
12. Karori SM, Ngure RM, Wachira FN, Wanyoko JK, Mwangi JN (2008). Different types of tea products attenuate inflammation induced in Trypanosoma brucei infected mice. Parasitol. Int., 57: 325-333.
13. Kim SH, Park HJ, Lee CM, Choi Il-W Moon DO, Ron HJ, Lee HK, Park YM (2006). Epigallocatechin-3-gallate protects toluene diisocyanateinduced airway inflammation in a murine model of asthma. FEBS. Lett., 580: 1883-1890.
14. Kundu JK, Surh J (2008). Inflammation: Gearing the journey to cancer. Mutat. Res., 659: 15-30.
15. Lee W, Min WK, Chun S, Lee YW, Park H, Lee DH, Lee YK, Son JE (2005). Long-term effects of green tea ingestion on atherosclerotic biological markers in smokers. Clin. Biochem., 38: 84-87.
16. Nakayama M, Suzuki K, Toda M, Okubo S, Hara Y, Shimamura T (1993). Inhibition of the infectivity of influenza virus by tea polyphenols. Antiviral. Res., 21: 289-299.
17. Narayana K, Urban JA, D'Souza KP, Rao S (2002). Ribavirin-induced sperm shape abnormalities in Wistar rat. Mutat. Res-Gen. Tox. En., 513: 193-196.
18. Patel S, Celermajer DS, Bao SS (2008). Atherosclerosis - Underlying inflammatory mechanisms and clinical implications. Int. J. Biochem. Cell Bio., 40: 576-580.
19. Ramesh E, Geraldine P, Thomas PA (2010). Regulatory effect of epigallocatechin gallate on the expression of C-reactive protein and other inflammatory markers in an experimental model of atherosclerosis. Chem-Biol. Interact., 183: 125-132.
20. Sakanaka S, Kim M, Taniguchi M, Yamamoto T (1989). Antibacterial substances in Japanese green tea extract against Streptococcus mutans, a cariogenic bacterium. Agr. Biol. Chem., 53: 2307-2311.
21. Sanderson H, Brain RA, Johnson DJ, Wilson CJ, Solomon KR (2004). Toxicity classification and evaluation of four pharmaceuticals classes: Antibiotics, antineoplastics, cardiovascular, and sex hormones. Toxicology, 203: 27-40.
22. Sarkar D, Fisher PB (2006). Molecular mechanisms of aging-associated inflammation. Cancer. Lett., 236: 13-23.
23. Schneider C, Segre T (2009). Green tea: Potential health benefits. Am. Fam. Phys., 79: 591-594.
24. Stapleton PD, Shah S, Anderson JC, Hara Y (2004). Modulation of β- lactam resistance in Staphylococcus aureus by catechins and gallates. Int. J. Antimicrob. Agents, 23: 462-467.
25. Stoicov C, Saffari R, Houghton J (2009). Green tea inhibits Helicobacter growth in vivo and in vitro. Int. J. Antimicrob. Agents, 33: 473-478.
26. Szczeklik A, Stevenson DD (2003). Aspirin-induced asthma: advances in pathogenesis, diagnosis, and management. J. Allergy Clin. Immun., 111: 913-921.
27. Wang YF, Ying L, Xu P, Zhang BY, Yang XQ, Qian LS (2011). Clinical evaluation of green tea polyphenols in treatment of pharyngitis in human subjects. Afr. J. Pharm. Pharmacol., 5: 336-341.
28. Wong S, Appleberg M, Ward CM, Lewis DR (2004). Aspirin resistance in cardiovascular disease: A review. Eur. J. Vasc. Endovasc., 27: 456-465.
29. Yamada H, Ohashi K, Atsumi T, Okabe H, Shimizu T, Nishio S, Li XD, Kosuge K, Watanabe H, Hara Y (2003). Effects of tea catechin inhalation on methicillin-resistant Staphylococcus aureus in elderly patients in a hospital ward. J. Hosp. Infect., 53: 229-231.
30. Yang XQ, Wang YF, Chen LJ (2003). Chemistry of Tea Polyphenols. Shanghai Science and Technology Publishing House: Shanghai.
31. Yu BP, Chung HY (2006). The inflammatory process in aging. Rev. Clin. Gerontol., 16: 179-187.